These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39395006)

  • 1. Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts.
    Li Y; Saba L; Scheinman RI; Banda NK; Holers M; Monte A; Dylla L; Moghimi SM; Simberg D
    ACS Nano; 2024 Oct; 18(42):28649-28658. PubMed ID: 39395006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.
    Benasutti H; Wang G; Vu VP; Scheinman R; Groman E; Saba L; Simberg D
    Bioconjug Chem; 2017 Nov; 28(11):2747-2755. PubMed ID: 29090582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
    Gifford G; Vu VP; Banda NK; Holers VM; Wang G; Groman EV; Backos D; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2019 May; 302():181-189. PubMed ID: 30974134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles.
    Vu VP; Gifford GB; Chen F; Benasutti H; Wang G; Groman EV; Scheinman R; Saba L; Moghimi SM; Simberg D
    Nat Nanotechnol; 2019 Mar; 14(3):260-268. PubMed ID: 30643271
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Wang G; Griffin JI; Inturi S; Brenneman B; Banda NK; Holers VM; Moghimi SM; Simberg D
    Front Immunol; 2017; 8():151. PubMed ID: 28239384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
    Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.
    Chen BM; Chen E; Lin YC; Tran TTM; Turjeman K; Yang SH; Cheng TL; Barenholz Y; Roffler SR
    ACS Nano; 2024 Aug; 18(33):22122-22138. PubMed ID: 39119697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement opsonization of nanoparticles: Differences between humans and preclinical species.
    Li Y; Wang G; Griffin L; Banda NK; Saba LM; Groman EV; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2021 Oct; 338():548-556. PubMed ID: 34481928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro.
    Neun BW; Barenholz Y; Szebeni J; Dobrovolskaia MA
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30002298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
    ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement.
    Estapé Senti M; de Jongh CA; Dijkxhoorn K; Verhoef JJF; Szebeni J; Storm G; Hack CE; Schiffelers RM; Fens MH; Boross P
    J Control Release; 2022 Jan; 341():475-486. PubMed ID: 34890719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.
    Chen F; Wang G; Griffin JI; Brenneman B; Banda NK; Holers VM; Backos DS; Wu L; Moghimi SM; Simberg D
    Nat Nanotechnol; 2017 May; 12(4):387-393. PubMed ID: 27992410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin
    Chen E; Chen BM; Su YC; Chang YC; Cheng TL; Barenholz Y; Roffler SR
    ACS Nano; 2020 Jul; 14(7):7808-7822. PubMed ID: 32142248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
    Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
    Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein adsorption on Fe
    Escamilla-Rivera V; Solorio-Rodríguez A; Uribe-Ramírez M; Lozano O; Lucas S; Chagolla-López A; Winkler R; De Vizcaya-Ruiz A
    Int J Nanomedicine; 2019; 14():2055-2067. PubMed ID: 30988608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines.
    Chen WA; Chang DY; Chen BM; Lin YC; Barenholz Y; Roffler SR
    ACS Nano; 2023 Mar; 17(6):5757-5772. PubMed ID: 36926834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin.
    Li Y; Ettah U; Jacques S; Gaikwad H; Monte A; Dylla L; Guntupalli S; Moghimi SM; Simberg D
    Mol Pharm; 2024 Jun; 21(6):3053-3060. PubMed ID: 38743264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.